Shengjie Zhu1, Prasanth Surampudi2, Baback Rosharavan3, Maria Chondronikola1,4. 1. Department of Nutrition, University of California Davis. 2. Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, University of California Davis. 3. Division of Nephrology, Department of Internal Medicine, University of California Davis, Davis, California, USA. 4. Department of Nutritional Sciences and Dietetics, Harokopio University of Athens, Athens, Greece.
Abstract
PURPOSE OF REVIEW: Intermittent fasting has been proposed as a potential nutrition approach against obesity and metabolic disease. Although data from studies in rodents convincingly support the antiobesity and cardiometabolic benefits of intermittent fasting, its effects in human health are still debatable. RECENT FINDINGS: Recent studies have examined the effect of two intermittent fasting approaches, that is, alternate day fasting (ADF) and time-restricted eating (TRE), on weight loss and cardiometabolic risk factors. ADF seems to be an equally effective weight loss approach to caloric restriction, but adherence to ADF is more challenging. ADF improves cardiometabolic risk factors, whereas it may have superior metabolic benefits compared to caloric restriction in people with insulin resistance. TRE with ad libitum food intake is well tolerated and induces 2-4% weight loss in approximatively 3 months. Additionally, TRE may have metabolic benefits particularly in people with metabolically abnormal obesity even without weight loss. SUMMARY: Intermittent fasting is a promising nutritional approach against obesity and its related metabolic diseases. Further research is needed to: i) establish the long-term effectiveness of TRE in weight loss and metabolic health, ii) improve the long-term adherence to ADF and investigate its weight loss independent effects in metabolic health, and iii) determine the mechanisms underlying the potential cardiometabolic benefits of intermittent fasting in humans.
PURPOSE OF REVIEW: Intermittent fasting has been proposed as a potential nutrition approach against obesity and metabolic disease. Although data from studies in rodents convincingly support the antiobesity and cardiometabolic benefits of intermittent fasting, its effects in human health are still debatable. RECENT FINDINGS: Recent studies have examined the effect of two intermittent fasting approaches, that is, alternate day fasting (ADF) and time-restricted eating (TRE), on weight loss and cardiometabolic risk factors. ADF seems to be an equally effective weight loss approach to caloric restriction, but adherence to ADF is more challenging. ADF improves cardiometabolic risk factors, whereas it may have superior metabolic benefits compared to caloric restriction in people with insulin resistance. TRE with ad libitum food intake is well tolerated and induces 2-4% weight loss in approximatively 3 months. Additionally, TRE may have metabolic benefits particularly in people with metabolically abnormal obesity even without weight loss. SUMMARY: Intermittent fasting is a promising nutritional approach against obesity and its related metabolic diseases. Further research is needed to: i) establish the long-term effectiveness of TRE in weight loss and metabolic health, ii) improve the long-term adherence to ADF and investigate its weight loss independent effects in metabolic health, and iii) determine the mechanisms underlying the potential cardiometabolic benefits of intermittent fasting in humans.
Authors: Grant M Tinsley; M Lane Moore; Austin J Graybeal; Antonio Paoli; Youngdeok Kim; Joaquin U Gonzales; John R Harry; Trisha A VanDusseldorp; Devin N Kennedy; Megan R Cruz Journal: Am J Clin Nutr Date: 2019-09-01 Impact factor: 7.045
Authors: Megumi Hatori; Christopher Vollmers; Amir Zarrinpar; Luciano DiTacchio; Eric A Bushong; Shubhroz Gill; Mathias Leblanc; Amandine Chaix; Matthew Joens; James A J Fitzpatrick; Mark H Ellisman; Satchidananda Panda Journal: Cell Metab Date: 2012-05-17 Impact factor: 27.287
Authors: Kelsey Gabel; Cynthia M Kroeger; John F Trepanowski; Kristin K Hoddy; Sofia Cienfuegos; Faiza Kalam; Krista A Varady Journal: Obesity (Silver Spring) Date: 2019-07-22 Impact factor: 5.002
Authors: John F Trepanowski; Cynthia M Kroeger; Adrienne Barnosky; Monica C Klempel; Surabhi Bhutani; Kristin K Hoddy; Kelsey Gabel; Sally Freels; Joseph Rigdon; Jennifer Rood; Eric Ravussin; Krista A Varady Journal: JAMA Intern Med Date: 2017-07-01 Impact factor: 21.873
Authors: Amy T Hutchison; Prashant Regmi; Emily N C Manoogian; Jason G Fleischer; Gary A Wittert; Satchidananda Panda; Leonie K Heilbronn Journal: Obesity (Silver Spring) Date: 2019-04-19 Impact factor: 5.002
Authors: Antonio J Vallejo-Vaz; Rana Fayyad; S Matthijs Boekholdt; G Kees Hovingh; John J Kastelein; Shari Melamed; Philip Barter; David D Waters; Kausik K Ray Journal: Circulation Date: 2018-08-21 Impact factor: 29.690
Authors: Humaira Jamshed; Robbie A Beyl; Deborah L Della Manna; Eddy S Yang; Eric Ravussin; Courtney M Peterson Journal: Nutrients Date: 2019-05-30 Impact factor: 5.717
Authors: Max C Petersen; Molly R Gallop; Stephany Flores Ramos; Amir Zarrinpar; Josiane L Broussard; Maria Chondronikola; Amandine Chaix; Samuel Klein Journal: Physiol Rev Date: 2022-07-14 Impact factor: 46.500